[ RECIPIENT ENTITY RECORD ]

MorphoSys

VERIFIED NODE ID: 001882 · morphosys-2
R TARGET NODE — CAPITAL RECIPIENT
MorphoSys
Company Germany
Recipient Type
Company
Primary Jurisdiction
Germany
Registration Status
ACTIVE
Entity Intelligence [ R ]
Legal Name MorphoSys
Entity Type Company
Jurisdiction Germany
Recipient Intelligence Summary

MorphoSys is a commercial-stage biopharmaceutical company dedicated to developing innovative therapies for patients with cancer and autoimmune diseases. Headquartered in Germany, the company utilizes advanced antibody and protein technologies for drug discovery. It was a primary destination for institutional healthcare capital through a strategic takeover.

Capital Influx Log (Transactions)
Date Type Amount
22 May 2026 EQUITY $2.9B